Showing results (331-340 of 377) with videos related to
Sort By:
Pageof 38
European Journal of Gastroenterology & Hepatology|October 19, 2016
Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patientsTadashi Namisaki, Kei Moriya, Mitsuteru Kitade, et al.Hepatology Communications|October 7, 2025
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trialYoshitaka Arase, Tomomi Okubo, Taeang Arai, et al.Digestive Diseases and Sciences|March 12, 2025
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular CarcinomaYuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, et al.Journal of Clinical Medicine|March 25, 2022
Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective StudyHideto Kawaratani, Yasuteru Kondo, Ryoji Tatsumi, et al.Journal of Gastroenterology|July 1, 2025
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapyTakanori Suzuki, Kentaro Matsuura, Yuki Tahata, et al.Plos One|October 11, 2016
Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis CKayoko Matsunami, Nao Nishida, Naoko Kaneko, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida, et al.Journal of Clinical Medicine|November 3, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening EndoscopyKoji Ishida, Tadashi Namisaki, Koji Murata, et al.Journal of Gastroenterology|November 5, 2021
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteriaNobuaki Nakayama, Hayato Uemura, Yoshihito Uchida, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 10, 2019
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosisNaotaka Shimozato, Tadashi Namisaki, Kosuke Kaji, et al.Pageof 38